Month: <span>May 2024</span>
Month: May 2024

Risk factors of substance use treatment gaps among a nationally representative sample of black American adults in relation to sexual minority status and health insurance coverage

BMC Psychol. 2024 May 15;12(1):271. doi: 10.1186/s40359-023-01352-7. ABSTRACT BACKGROUND: Little research has investigated predictors of specialty substance use treatment gaps among Black adults. This study …

Synergizing Safety: A Customized Approach to Curtailing Unplanned Extubations through Shared Decision-making in the NICU

Pediatr Qual Saf. 2024 May 9;9(3):e729. doi: 10.1097/pq9.0000000000000729. eCollection 2024 May-Jun. ABSTRACT BACKGROUND: Unplanned Extubation (UE) remains an important patient safety issue in the Neonatal …

Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID-19: Results From Four Health Systems, 2015-2023

Influenza Other Respir Viruses. 2024 May;18(5):e13298. doi: 10.1111/irv.13298. ABSTRACT BACKGROUND: Respiratory syncytial virus (RSV) is a substantial cause of infant morbidity and mortality due to …

Individualised dosing of follitropin delta affects live birth and safety in IVF: an individual participant data meta-analysis of randomised controlled trials

Fertil Steril. 2024 May 13:S0015-0282(24)00453-9. doi: 10.1016/j.fertnstert.2024.05.143. Online ahead of print. ABSTRACT IMPORTANCE: For women undertaking assisted conception, the dose of gonadotropin has historically been …

Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension

Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.123.068107. Online ahead of print. ABSTRACT BACKGROUND: Sildenafil, approved for pulmonary arterial hypertension (PAH), has a recommended adult dose of …